Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1997-08-14
2000-08-22
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
424542, 530350, 530856, 514 2, A61K 3848
Patent
active
061068306
ABSTRACT:
A pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases which comprises as an effective ingredient batroxobin.
REFERENCES:
patent: 3849252 (1974-11-01), Percs et al.
patent: 5595974 (1997-01-01), Tomaru
Takanashi et al. (CA 104:14790, abstract of Oyo Yakari, (1985), 30 (3), pp. 481-486).
Ozaki et al., (CA 99:169290, abstract of Oyo Yakuri (1983), 26 (1), pp. 55-77).
Tanaka et al., (CA 93: 180638, abstract of Ketsueki to Myakkan (1980), 11 (1), pp. 30-34).
Peigen Kuang et al., (CA96:455640, Source : Third Meeting of the Asian-Pacific Society for Neurochemistry and Fifth Meeting of the Chinese Society for Neurochemistry, Beijing, China, Oct. 8-10, 1996. Journal of Neurochemistry 67 (Suppl.), 1996, S29, ISSN: 0022-3042.
Kuang, P. et al., (AN 97-054438-06, WPIDS, abstract of EP 750912), 1997.
Toulon P. et al., (AN 94:93463, Thirty-fifth Annual Meeting of the American Society of Hematology, St. Louis, Missouri, USA, Dec. 3-7, 1993. Blood 82 (10 Suppl. 1). 1993. 155A. ISSN: 0006-4571).
Merck Index 11th edition, 1989, #1020.
P. Fernandez, et al., Proc. Natl. Acad. Sci. USA, vol. 91, pp. 8641-8645, "Expression of a Specific Marker of Avian Programmed Cell Death in Both Apoptosis and Necrosis", Aug. 1994.
J. F. R. Kerr, et al. "Apoptosis: A Basic Biological Phenomenon with Wide-Ranging Implications in Tissue Kinetics", British Journal of Cancer, No. 26, 1972, pp. 239-257.
Gerard I. Evan, et al. "Induction of Apoptosis in Fibroblasts by C-MYC Protein", Cell , vol. 69, Apr. 3, 1992, pp. 119-128.
A. R. Clarke, et al., "Thymocyte Apoptosis Induced by p53-Dependent and Independent Pathways", Nature, vol. 362, Apr. 29, 1993, pp. 849-852.
Reid P. Bissonnette, et al., "Apoptotic Cell Death Induced by C-MYC is Inhibited by BCL-2", Nature, vol. 359, Oct. 8, 1992, pp. 552-554.
Abdallah Fanidi, et al., "Cooperative Interaction Between C-MYC and BCL-2 Proto-Oncogenes", Nature, vol. 359, Oct. 8, 1992, pp. 554-556.
Craig B. Thompson "Apoptosis in the Pathogenesis and Treatment of Disease", Science, vol. 267, Mar. 10, 1995, pp. 1456-1462.
Maj-Lis Smith, et al. "Models for Studying Long-Term Recovery Following Forebrain Ischemia in the Rat. 2. A 2-Vessel Occlusion Model", Acta Neurol Scand, No. 69, 1984, pp. 385-401.
Yael Gavrieli, et al. "Identification of Programmed Cell Death in Situ Via Specific Labeling of Nuclear DNA Fragmentation", The Journal of Cell Biology, vol. 119, No. 3, Nov. 1992, pp. 493-501.
Yuriko Tanaka et al, "Studies on the mechanism of activation of fibrinogen by thrombin or snake venom (Defibrase)", Blood & Vessel, vol. 11, pp. 30-34, 1980.
Dees Jos,e G.
Qazi Sabiha
Tobishi Pharmaceutical Co., Ltd.
LandOfFree
Methods for the treatment of apoptosis-related diseases by batro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the treatment of apoptosis-related diseases by batro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of apoptosis-related diseases by batro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-577539